Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference
Rhea-AI Summary
Eledon Pharmaceuticals (Nasdaq: ELDN) announced that CEO David-Alexandre C. Gros, M.D. will participate in a fireside chat at the 37th Annual Piper Sandler Healthcare Conference on Thursday, December 4, 2025 at 8:50 a.m. ET (5:50 a.m. PT).
The session will be available via live webcast with a replay accessible on the company website under Events for registered attendees.
Positive
- None.
Negative
- None.
IRVINE, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer will participate in a fireside chat at the upcoming 37th Annual Piper Sandler Healthcare Conference on Thursday, December 4, 2025 at 8:50 a.m. ET (5:50 a.m. PT).
To register in advance for the fireside chat webcast, sign up here.
A webcast replay will be accessible following the live session on the Company’s website under Events.
About Eledon Pharmaceuticals and tegoprubart
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company that is developing immune-modulating therapies for the management and treatment of life-threatening conditions. The Company’s lead investigational product is tegoprubart, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential. The central role of CD40L signaling in both adaptive and innate immune cell activation and function positions it as an attractive target for non-lymphocyte depleting, immunomodulatory therapeutic intervention. The Company is building upon a deep historical knowledge of anti-CD40 Ligand biology to conduct preclinical and clinical studies in kidney allograft transplantation, xenotransplantation, and amyotrophic lateral sclerosis (ALS). Eledon is headquartered in Irvine, California. For more information, please visit the Company’s website at www.eledon.com.
Follow Eledon Pharmaceuticals on social media: LinkedIn; Twitter
Investor Contact:
Stephen Jasper
Gilmartin Group
(858) 525 2047
stephen@gilmartinir.com
Media Contact:
Jenna Urban
CG Life
(212) 253 8881
jurban@cglife.com
Source: Eledon Pharmaceuticals
FAQ
When will Eledon (ELDN) present at the Piper Sandler Healthcare Conference?
Who from Eledon (ELDN) will speak at the December 4, 2025 fireside chat?
How can investors watch Eledon (ELDN) at the 37th Annual Piper Sandler Healthcare Conference?
What time is Eledon's (ELDN) webcast for Pacific Time on December 4, 2025?
Will a replay of Eledon's (ELDN) Piper Sandler presentation be available after the event?
